FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103305097> ?p ?o ?g. }

• W2103305097 endingPage "52" @default.
• W2103305097 startingPage "41" @default.
• W2103305097 abstract "Introduction: Data reported during the last decade of the twentieth century indicate that passive targeting is an efficient strategy for delivering nanocarrier systems to tumor tissues. The focus of this review is on active targeting as a next-generation strategy for extending the capacity of a drug delivery system (DDS).Areas covered: Tumor vasculature targeting was achieved using arginine- glycine-aspartic acid, asparagine-glycine-arginine and other peptides, which are well-known peptides, as ligand against tumor vasculature. An efficient system for delivering small interfering RNA to the tumor vasculature involved the use of a multifunctional envelope-type nanodevice based on a pH-modified cationic lipid and targeting ligands. The active-targeting system was extended from tumor delivery to adipose tissue delivery, where endothelial cells are tightly linked and are impermeable to nanocarriers. In mice, prohibitin-targeted nanoparticles can be used to successfully deliver macromolecules to induce anti-obese effects. Finally, the successful delivery of nanocarriers to adipose tissue in obese mice via the enhanced permeability and retention-effect is reported, which can be achieved in tumor tissue.Expert opinion: Unlike tumor tissues, only a few reports have appeared on how liposomal carriers accumulate in adipose tissues after systemic injection. This finding, as well as active targeting to the adipose vasculature, promises to extend the capacity of DDS to adipose tissue. Since the site of action of nucleic acids is the cytosol, the intracellular trafficking of carriers and their cargoes as well as cellular uptake must be taken into consideration." @default.
• W2103305097 created "2016-06-24" @default.
• W2103305097 creator A5006918664 @default.
• W2103305097 creator A5015535493 @default.
• W2103305097 creator A5015662992 @default.
• W2103305097 creator A5063023594 @default.
• W2103305097 date "2014-11-07" @default.
• W2103305097 modified "2023-10-05" @default.
• W2103305097 title "Advances in an active and passive targeting to tumor and adipose tissues" @default.
• W2103305097 cites W1547687419 @default.
• W2103305097 cites W1567156395 @default.
• W2103305097 cites W1585705786 @default.
• W2103305097 cites W1587050401 @default.
• W2103305097 cites W1607665397 @default.
• W2103305097 cites W161301567 @default.
• W2103305097 cites W190672668 @default.
• W2103305097 cites W1955264006 @default.
• W2103305097 cites W1964146045 @default.
• W2103305097 cites W1967927190 @default.
• W2103305097 cites W1969157495 @default.
• W2103305097 cites W1969402650 @default.
• W2103305097 cites W1970038366 @default.
• W2103305097 cites W1972970472 @default.
• W2103305097 cites W1978872101 @default.
• W2103305097 cites W1980249918 @default.
• W2103305097 cites W1980959618 @default.
• W2103305097 cites W1983992525 @default.
• W2103305097 cites W1984574632 @default.
• W2103305097 cites W1988313934 @default.
• W2103305097 cites W1995098796 @default.
• W2103305097 cites W1995770815 @default.
• W2103305097 cites W1999239339 @default.
• W2103305097 cites W2012263583 @default.
• W2103305097 cites W2014509855 @default.
• W2103305097 cites W2014928486 @default.
• W2103305097 cites W2015269201 @default.
• W2103305097 cites W2017168333 @default.
• W2103305097 cites W2017322644 @default.
• W2103305097 cites W2018723375 @default.
• W2103305097 cites W2021724108 @default.
• W2103305097 cites W2022666976 @default.
• W2103305097 cites W2026889244 @default.
• W2103305097 cites W2027442301 @default.
• W2103305097 cites W2028469454 @default.
• W2103305097 cites W2028904367 @default.
• W2103305097 cites W2031630601 @default.
• W2103305097 cites W2032028642 @default.
• W2103305097 cites W2032315087 @default.
• W2103305097 cites W2032359181 @default.
• W2103305097 cites W2034108625 @default.
• W2103305097 cites W2035187804 @default.
• W2103305097 cites W2037642226 @default.
• W2103305097 cites W2041925658 @default.
• W2103305097 cites W2042619042 @default.
• W2103305097 cites W2044569715 @default.
• W2103305097 cites W2051143941 @default.
• W2103305097 cites W2053515735 @default.
• W2103305097 cites W2053938092 @default.
• W2103305097 cites W2054728198 @default.
• W2103305097 cites W2056644518 @default.
• W2103305097 cites W2058335137 @default.
• W2103305097 cites W2058879480 @default.
• W2103305097 cites W2062264676 @default.
• W2103305097 cites W2063489655 @default.
• W2103305097 cites W2064227792 @default.
• W2103305097 cites W2065902356 @default.
• W2103305097 cites W2067557497 @default.
• W2103305097 cites W2068725718 @default.
• W2103305097 cites W2074395402 @default.
• W2103305097 cites W2075800885 @default.
• W2103305097 cites W2076226743 @default.
• W2103305097 cites W2081492008 @default.
• W2103305097 cites W2082511916 @default.
• W2103305097 cites W2082528772 @default.
• W2103305097 cites W2085434191 @default.
• W2103305097 cites W2087795552 @default.
• W2103305097 cites W2088659772 @default.
• W2103305097 cites W2090892913 @default.
• W2103305097 cites W2091993321 @default.
• W2103305097 cites W2092566647 @default.
• W2103305097 cites W2096694018 @default.
• W2103305097 cites W2098387318 @default.
• W2103305097 cites W2113676592 @default.
• W2103305097 cites W2115824449 @default.
• W2103305097 cites W2120198019 @default.
• W2103305097 cites W2123629654 @default.
• W2103305097 cites W2126044151 @default.
• W2103305097 cites W2127509551 @default.
• W2103305097 cites W2129103044 @default.
• W2103305097 cites W2132257982 @default.
• W2103305097 cites W2132497528 @default.
• W2103305097 cites W2133756116 @default.
• W2103305097 cites W2137634849 @default.
• W2103305097 cites W2150048971 @default.
• W2103305097 cites W2152342778 @default.
• W2103305097 cites W2152529303 @default.
• W2103305097 cites W2153496048 @default.
• W2103305097 cites W2153961808 @default.

• next